Literature DB >> 26232631

Comparison of transcriptomic responses to pancreas disease (PD) and heart and skeletal muscle inflammation (HSMI) in heart of Atlantic salmon (Salmo salar L).

Lill-Heidi Johansen1, Hanna L Thim2, Sven Martin Jørgensen3, Sergey Afanasyev4, Guro Strandskog2, Torunn Taksdal5, Kjersti Fremmerlid2, Marion McLoughlin6, Jorunn B Jørgensen2, Aleksei Krasnov3.   

Abstract

Pancreas disease (PD) and heart and skeletal muscle inflammation (HSMI) are viral diseases associated with SAV (salmonid alphavirus) and PRV (piscine reovirus), which induce systemic infections and pathologies in cardiac and skeletal muscle tissue of farmed Atlantic salmon (Salmo salar L), resulting in severe morbidity and mortality. While general features of the clinical symptoms and pathogenesis of salmonid viral diseases are relatively well studied, much less is known about molecular mechanisms associated with immunity and disease-specific changes. In this study, transcriptomic analyses of heart tissue from PD and HSMI challenged Atlantic salmon were done, focusing on the mature phases of both diseases at respectively 28-35 and 42-77 days post infection. A large number of immune genes was activated in both trials with prevalence of genes associated with early innate antiviral responses, their expression levels being slightly higher in PD challenged fish. Activation of the IFN axis was in parallel with inflammatory changes that involved diverse humoral and cellular factors. Adaptive immune response genes were more pronounced in fish with HSMI, as suggested by increased expression of a large number of genes associated with differentiation and maturation of B lymphocytes and cytotoxic T cells. A similar down-regulation of non-immune genes such as myofiber and mitochondrial proteins between diseases was most likely reflecting myocardial pathology. A suite of genes important for cardiac function including B-type natriuretic peptide and four neuropeptides displayed differential expression between PD and HSMI. Comparison of results revealed common and distinct features and added to the understanding of both diseases at their mature phases with typical clinical pictures. A number of genes that showed disease-specific changes can be of interest for diagnostics.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atlantic salmon; Heart; Heart and skeletal muscle inflammation; Immune genes; Pancreas disease; Transcriptomic responses

Mesh:

Year:  2015        PMID: 26232631     DOI: 10.1016/j.fsi.2015.07.023

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  17 in total

1.  Effect of vaccines against pancreas disease in farmed Atlantic salmon.

Authors:  Magnus Vikan Røsaeg; Ragnar Thorarinsson; Arnfinn Aunsmo
Journal:  J Fish Dis       Date:  2021-08-17       Impact factor: 2.580

2.  The C-Terminal Domain of Salmonid Alphavirus Nonstructural Protein 2 (nsP2) Is Essential and Sufficient To Block RIG-I Pathway Induction and Interferon-Mediated Antiviral Response.

Authors:  Raphaël Jami; Emilie Mérour; Julie Bernard; Annie Lamoureux; Jean K Millet; Stéphane Biacchesi
Journal:  J Virol       Date:  2021-09-15       Impact factor: 5.103

3.  Experimental Piscine orthoreovirus infection mediates protection against pancreas disease in Atlantic salmon (Salmo salar).

Authors:  Morten Lund; Magnus Vikan Røsæg; Aleksei Krasnov; Gerrit Timmerhaus; Ingvild Berg Nyman; Vidar Aspehaug; Espen Rimstad; Maria Krudtaa Dahle
Journal:  Vet Res       Date:  2016-10-21       Impact factor: 3.683

4.  Infection with purified Piscine orthoreovirus demonstrates a causal relationship with heart and skeletal muscle inflammation in Atlantic salmon.

Authors:  Øystein Wessel; Stine Braaen; Marta Alarcon; Hanne Haatveit; Norbert Roos; Turhan Markussen; Torstein Tengs; Maria K Dahle; Espen Rimstad
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

5.  Identification of differentially expressed Atlantic salmon miRNAs responding to salmonid alphavirus (SAV) infection.

Authors:  Rune Andreassen; Nardos Tesfaye Woldemariam; Ine Østråt Egeland; Oleg Agafonov; Hilde Sindre; Bjørn Høyheim
Journal:  BMC Genomics       Date:  2017-05-04       Impact factor: 3.969

6.  De novo assembly of Sockeye salmon kidney transcriptomes reveal a limited early response to piscine reovirus with or without infectious hematopoietic necrosis virus superinfection.

Authors:  Mark P Polinski; Julia C Bradshaw; Sabrina M Inkpen; Jon Richard; Camilla Fritsvold; Trygve T Poppe; Matthew L Rise; Kyle A Garver; Stewart C Johnson
Journal:  BMC Genomics       Date:  2016-11-02       Impact factor: 3.969

7.  Heart and skeletal muscle inflammation (HSMI) disease diagnosed on a British Columbia salmon farm through a longitudinal farm study.

Authors:  Emiliano Di Cicco; Hugh W Ferguson; Angela D Schulze; Karia H Kaukinen; Shaorong Li; Raphaël Vanderstichel; Øystein Wessel; Espen Rimstad; Ian A Gardner; K Larry Hammell; Kristina M Miller
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

8.  Identification of genetic loci associated with higher resistance to pancreas disease (PD) in Atlantic salmon (Salmo salar L.).

Authors:  Borghild Hillestad; Shokouh Makvandi-Nejad; Aleksei Krasnov; Hooman K Moghadam
Journal:  BMC Genomics       Date:  2020-06-03       Impact factor: 3.969

9.  Quantitative trait loci and genes associated with salmonid alphavirus load in Atlantic salmon: implications for pancreas disease resistance and tolerance.

Authors:  M L Aslam; D Robledo; A Krasnov; H K Moghadam; B Hillestad; R D Houston; M Baranski; S Boison; N A Robinson
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.379

10.  Infection experiments with novel Piscine orthoreovirus from rainbow trout (Oncorhynchus mykiss) in salmonids.

Authors:  Helena Hauge; Niccolo Vendramin; Torunn Taksdal; Anne Berit Olsen; Øystein Wessel; Susie Sommer Mikkelsen; Anna Luiza Farias Alencar; Niels Jørgen Olesen; Maria Krudtaa Dahle
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.